PNU 157706, a novel dual type I and II5α-reductase inhibitor
- 1 February 1998
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 64 (3-4) , 179-186
- https://doi.org/10.1016/s0960-0760(97)00158-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in menJournal of Clinical Endocrinology & Metabolism, 1996
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effectsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- 5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitroJournal of Clinical Endocrinology & Metabolism, 1996
- Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitorsThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Effects of 5α-reductase inhibitors on intraprostatic androgens in the ratThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- 5α‐Reductase inhibitors and prostatic diseaseClinical Endocrinology, 1994
- Novel aromatase and 5α-reductase inhibitorsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Baculovirus-directed expression of human prostatic steroid 5α-reductase 1 in an active formThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- FinasterideDrugs, 1993
- Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic responseEndocrinology, 1992